enroxil 100 100 mg/ml inj. sol. s.c./i.v. vial
krka d.d. novo mesto d.d. - enrofloxacin 100 mg/ml - solution for injection - 100 mg/ml - enrofloxacin 100 mg/ml - enrofloxacin - cattle
enrofloxacin medimarket 5% veterinay
a.l. medi-market ltd. - enrofloxacin - solution for injection - enrofloxacin 50 mg / 1 ml - in calves:treatment of infections of the respiratory tract caused by enrofloxacin susceptible strains of pasteurella multocida, mannheimia haemolytica and mycoplasma spp. treatment of infections of the alimentary tract caused by enrofloxacin susceptible strains of escherichia coli. treatment of septicaemia caused by enrofloxacin susceptible strains of escherichia coli. treatment of acute mycoplasma-associated arthritis due to enrofloxacin susceptible strains of mycoplasma bovis.only after the sensitivity of the bacteria has been proven and it has been found that there is no alternative treatment (proven resistance to other agents).
enrofloxacin flavored- enrofloxacin tablet
felix pharmaceuticals private limited - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - enrofloxacin flavored tablets are indicated for the management of diseases associated with bacteria susceptible to enrofloxacin. enrofloxacin flavored tablets are indicated for use in dogs and cats. enrofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones. dogs: based on the studies discussed under the section on animal safety summary, the use of enrofloxacin is contraindicated in small and medium breeds of dogs during the rapid growth phase (between 2 and 8 months of age). the safe use of enrofloxacin has not been established in large and giant breeds during the rapid growth phase. large breeds may be in this phase for up to one year of age and the giant breeds for up to 18 months. in clinical field trials utilizing a daily oral dose of 5.0 mg/kg, there were no reports of lameness or joint problems in any breed. however, controlled studies with histological examination of the articular cartilage have not been conducted in the large or giant breeds.
enrofloxacin flavored- enrofloxacin tablet
butler animal health supply, llc dba covetrus north america - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - enrofloxacin flavored tablets are indicated for the management of diseases associated with bacteria susceptible to enrofloxacin. enrofloxacin flavored tablets are indicated for use in dogs and cats. enrofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones. dogs: based on the studies discussed under the section on animal safety summary, the use of enrofloxacin is contraindicated in small and medium breeds of dogs during the rapid growth phase (between 2 and 8 months of age). the safe use of enrofloxacin has not been established in large and giant breeds during the rapid growth phase. large breeds may be in this phase for up to one year of age and the giant breeds for up to 18 months. in clinical field trials utilizing a daily oral dose of 5.0 mg/kg, there were no reports of lameness or joint problems in any breed. however, controlled studies with histological examination of the articular cartilage have not been conducted in the large or giant breeds.
enrofloxacin solution
butler animal health supply, llc dba covetrus north america - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - enrofloxacin injectable solution is indicated for the management of diseases in dogs associated with bacteria susceptible to enrofloxacin. enrofloxacin is contraindicated in dogs known to be hypersensitive to quinolones. based on the studies discussed under the section on animal safety summary, the use of enrofloxacin is contraindicated in small and medium breeds of dogs during the rapid growth phase (between 2 and 8 months of age). the safe use of enrofloxacin has not been established in large and giant breeds during the rapid growth phase. large breeds may be in this phase for up to one year of age and the giant breeds for up to 18 months. in clinical field trials utilizing a daily oral dose of 5.0 mg/kg, there were no reports of lameness or joint problems in any breed. however, controlled studies with histological examination of the articular cartilage have not been conducted in the large or giant breeds.
enrox 100 mg/ml oral solution
krka, d.d., novo mesto - enrofloxacin - oral solution - 100 mg/ml - enrofloxacin - fowl - chicken, fowl - turkey - antibacterial
enrox flavour 15 mg tablets for dogs and cats
krka, d.d., novo mesto - enrofloxacin - tablets - 15 mg/tablet - enrofloxacin - canine, feline - antibacterial
enrox flavour 150 mg tablets for dogs
krka, d.d., novo mesto - enrofloxacin - tablets - 150 mg/tablet - enrofloxacin - canine - antibacterial
enrox flavour 50 mg tablets for dogs
krka, d.d., novo mesto - enrofloxacin - tablets - 50 mg/tablet - enrofloxacin - canine - antibacterial
enrox 100 mg/ml oral solution
krka, d.d., novo mesto - enrofloxacin - oral solution - 100 milligram(s)/millilitre - enrofloxacin - chickens, turkeys - antibacterial